Profound Medical Corp. (NASDAQ: PROF) reported Q2 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $5.08 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.